Glutamatergic Modulation to Facilitate Naltrexone Initiation in Opioid Dependence
Clinical trial NCT02437344 · COMPLETED
Trial details
- NCT number
- NCT02437344
- Sponsor
- New York State Psychiatric Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2016-12-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.